214 related articles for article (PubMed ID: 21928365)
1. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
[TBL] [Abstract][Full Text] [Related]
2. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
[No Abstract] [Full Text] [Related]
5. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
[TBL] [Abstract][Full Text] [Related]
6. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
[TBL] [Abstract][Full Text] [Related]
8. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.
Kim BK; Kim JS; Oh C; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):705-14. PubMed ID: 21626042
[TBL] [Abstract][Full Text] [Related]
9. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.
Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
11. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.
Choi HH; Kim JS; Yoon DH; Hong KS; Kim TH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Mar; 28(3):491-7. PubMed ID: 21442265
[TBL] [Abstract][Full Text] [Related]
12. Effect of neointimal tissue morphology on vascular response to balloon angioplasty in lesions with in-stent restenosis after drug-eluting stent deployment: an optical coherence tomography analysis.
Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Shimatani Y; Hasegawa K; Ishibuchi K; Tamaru H; Ishii R; Yasuda S; Taniguchi Y; Nakabayashi S; Kusumoto H; Higashino Y
Heart Vessels; 2020 Sep; 35(9):1193-1200. PubMed ID: 32253529
[TBL] [Abstract][Full Text] [Related]
13. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
[TBL] [Abstract][Full Text] [Related]
14. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
Kim HO; Jung HW; Lee JH; Kim JS; Hong SJ; Ahn CM; Kim BK; Kim W; Kim SJ; Kim W; Ko YG; Choi D; Hong MK; Jang Y
Coron Artery Dis; 2020 Dec; 31(8):694-702. PubMed ID: 32976245
[TBL] [Abstract][Full Text] [Related]
15. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
[TBL] [Abstract][Full Text] [Related]
16. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
Trials; 2012 May; 13():55. PubMed ID: 22559260
[TBL] [Abstract][Full Text] [Related]
17. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
[No Abstract] [Full Text] [Related]
18. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
[TBL] [Abstract][Full Text] [Related]
19. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
20. Qualitative and quantitative assessment of stent restenosis by optical coherence tomography: comparison between drug-eluting and bare-metal stents.
Nagoshi R; Shinke T; Otake H; Shite J; Matsumoto D; Kawamori H; Nakagawa M; Kozuki A; Hariki H; Inoue T; Ohsue T; Taniguchi Y; Iwasaki M; Nishio R; Hiranuma N; Konishi A; Kinutani H; Miyoshi N; Takaya T; Yamada S; Yasaka Y; Hayashi T; Yokoyama M; Kato H; Kadotani M; Ohnishi Y; Hirata K
Circ J; 2013; 77(3):652-60. PubMed ID: 23257388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
